Pancreatic Pre-Cancerous Lesions Remain Stable Due to Microenvironment
Researchers reported that hundreds of pre-cancerous lesions called PanINs form in the pancreas after age 40. The lesions rarely progress to pancreatic ductal adenocarcinoma because of protective factors in the surrounding tissue environment.
news-medical.netResearchers reported that hundreds of pre-cancerous lesions called PanINs form in the pancreas after age 40. The lesions rarely progress to pancreatic ductal adenocarcinoma because of protective factors in the surrounding tissue environment. The microenvironment surrounding the lesions appears to limit progression to cancer.
Officials at the institutions conducting the research stated that this protective mechanism explains why most PanINs remain stable.
PanINs are considered pre-cancerous lesions.
They occur frequently in adults over age 40 but seldom advance to pancreatic ductal adenocarcinoma. The new findings focus on the role of the tissue environment around the lesions. Researchers said the microenvironment provides a barrier that prevents most lesions from becoming invasive cancer.
Further studies are planned to examine how the microenvironment maintains stability. Officials said additional work could identify ways to strengthen these protective effects.
Key Facts
Potential Impact
- 01
New research may guide future studies on preventing pancreatic cancer progression.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…